Clinical Result of One-Piece Aspheric Intraocular Lens in Mild Zonule-Weakness

Purpose: To compare the clinical outcomes of one-piece aspheric intraocular lens in the patient group with mild zonule weakness and control group.Method: Among the patients who underwent cataract surgery since 2017, 30 patients (average age of 68.26 ± 8.99 years, 14 men, 16 women) and 35 eyes were selected. Prior to surgery, information on LOCS staging, endothelial cell count, intraocular pressure, axial length, and corneal refractive index were analyzed retrospectively. The average follow-up period after surgery was 3 months. The absolute value of the difference between the spherical equivalent value and the target refractive value in the patient group and the control group at 1 month and 3 months after surgery was compared.Results: The absolute value of the difference in refractive value after 1 month in the patient group was found was 0.61 ± 0.41 Diopters and 0.51 ± 0.42 Diopters in the control group, showing no statistically significant difference (p > 0.05). After 3 months, the absolute value of the refractive value difference was 0.46 ± 0.27 Diopters in the patient group and 0.46 ± 0.32 Diopters in the control group, indicating no statistically significant difference (p > 0.05).Conclusions: The one-piece aspheric intraocular lens enVista MX60 does not show statistically significant clinical difference in the difference between the postoperative refractive value and the target refractive value in the patient group, so it may be actively considered for use in the patient with mild zonule weakness.